ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1253

Patient Reported Outcomes Explain the Lack of Agreement between Physician and Patient Perceived Remission in Early Rheumatoid Arthritis

Samina A. Turk1,2, Linda A. Rasch3, Willem F. Lems4,5, Lilian van Tuyl3, Dirkjan van Schaardenburg4,6 and Marieke M. Ter Wee5,7, 1Rheumatology, Amsterdam Rheumatology and immunology Center | Reade, Amsterdam, Netherlands, 2Rheumatology, Amsterdam Rheumatology and immunology Center | Academic Medical Center, Amsterdam, Netherlands, 3Amsterdam Rheumatology and immunology Center | VU University Medical Center, Amsterdam, Netherlands, 4Amsterdam Rheumatology and immunology Center | Reade, Amsterdam, Netherlands, 5Rheumatology, Amsterdam Rheumatology and immunology Center | VU University Medical Center, Amsterdam, Netherlands, 6Amsterdam Rheumatology and immunology Center | Academic Medical Center, Amsterdam, Netherlands, 7Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, Netherlands

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Early Rheumatoid Arthritis, Patient questionnaires, patient-reported outcome measures and remission

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Patient Outcomes, Preferences, and Attitudes Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Rheumatoid arthritis (RA) patients increasingly reach a state of absence of disease activity, or remission. However, the proportion of patients classified as in remission varies substantially between definitions and are often determined by disease activity score (DAS) of the joints. But, the importance of patients’ perspective is increasingly recognized, which often result in discordance between patients and physician assessment.

Objectives:

First, agreement between patient-perceived, physician-perceived remission and clinical response and remission definitions was determined in early RA patients. Second, the differences in clinical and patient-reported outcomes, in patients in physician-perceived remission, between patients in and not in self-perceived remission were assessed.

Methods:

In early RA patients receiving COBRA-light treatment, DAS44, ACR/EULAR Boolean-based remission, EULAR good and ACR70 response were determined after 12 weeks. Agreement percentages and kappa values between patient-perceived, physician-perceived remission and clinical response and remission definitions were calculated. In patients in physician-perceived remission, improvement in clinical and patient-reported outcomes (RAID) were compared between patients in and not in self-perceived remission.

Results:

Eighty-four consecutive patients were included (mean age 50 years, 67% female). Agreement between the assessed outcome measures differed enormously. The agreement between physician-perceived and patient-perceived remission was 64% (kappa 0.25, p<0.01). Physician-perceived remission (cut-off VAS ≤20 mm) had the best agreement with EULAR good response (86%, kappa 0.58, p<0.01). Agreement between patient-perceived remission was 69% for EULAR good and ACR70 response (kappa 0.36, p<0.01; kappa 0.40, p<0.01, respectively). Patients not in self-perceived remission improved less on components of the RAID, especially on pain, sleep and emotional well-being.

Conclusion:

One-third of the early RA patients disagreed with the physician on being in remission. Those patients had less improvement on components of the RAID, especially on pain, sleep and emotional well-being. Together with the variability in clinical response and remission definitions, these results highlight the need to increase patient involvement in their own health care decisions.

Table. Agreement between different definitions of response and remission.

Physician-

perceived  remission (≤10 mm)

Physician-

perceived  remission (≤20 mm)

Patient-

perceived  remission

DAS44 remission

EULAR good response

ACR70 response

Boolean remission

Physician-

perceived  remission (≤10 mm)

x

86%

Ƙ=0.650

P=0.000

67%

Ƙ=0.318

P=0.003

74%

Ƙ=0.439

P=0.000

79%

Ƙ=0.484

P=0.000

60%

Ƙ=0.281

P=0.001

57%

Ƙ=0.248

P=0.002

Physician-

perceived  remission (≤20 mm)

86%

Ƙ=0.650

P=0.000

x

64%

Ƙ=0.254

P=0.005

64%

Ƙ=0.454

P=0.000

86%

Ƙ=0.576

P=0.000

45%

Ƙ=0.117

P=0.069

48%

Ƙ=0.175

P=0.005

Patient-perceived remission

67%

Ƙ=0.318

P=0.003

64%

Ƙ=0.254

P=0.005

x

46%

Ƙ=0.516

P=0.000

69%

Ƙ=0.356

P=0.000

69%

Ƙ=0.398

P=0.000

67%

Ƙ=0.354

P=0.000

DAS44 remission

74%

Ƙ=0.439

P=0.000

64%

Ƙ=0.454

P=0.000

46%

Ƙ=0.516

P=0.000

x

83%

Ƙ=0.622

P=0.000

64%

Ƙ=0.343

P=0.000

67%

Ƙ=0.392

P=0.000

EULAR good response

79%

Ƙ=0.484

P=0.000

86%

Ƙ=0.576

P=0.000

69%

Ƙ=0.356

P=0.000

83%

Ƙ=0.622

P=0.000

x

52%

Ƙ=0.220

P=0.001

50%

Ƙ=0.199

P=0.002

ACR70 response

60%

Ƙ=0.281

P=0.001

45%

Ƙ=0.117

P=0.069

69%

Ƙ=0.398

P=0.000

64%

Ƙ=0.343

P=0.000

52%

Ƙ=0.220

P=0.001

x

74%

Ƙ=0.359

P=0.001

Boolean remission

57%

Ƙ=0.248

P=0.002

48%

Ƙ=0.175

P=0.005

67%

Ƙ=0.354

P=0.000

67%

Ƙ=0.392

P=0.000

50%

Ƙ=0.199

P=0.002

74%

Ƙ=0.359

P=0.001

x

Numbers are presented as level of agreement (%), kappa value (K) and p-value (P).

Figure.


Disclosure: S. A. Turk, None; L. A. Rasch, None; W. F. Lems, None; L. van Tuyl, None; D. van Schaardenburg, None; M. M. Ter Wee, None.

To cite this abstract in AMA style:

Turk SA, Rasch LA, Lems WF, van Tuyl L, van Schaardenburg D, Ter Wee MM. Patient Reported Outcomes Explain the Lack of Agreement between Physician and Patient Perceived Remission in Early Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/patient-reported-outcomes-explain-the-lack-of-agreement-between-physician-and-patient-perceived-remission-in-early-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-reported-outcomes-explain-the-lack-of-agreement-between-physician-and-patient-perceived-remission-in-early-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology